Rheumatology Doctors in San Luis Obispo, CA Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Mr. Barry Eibschutz, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1039 Murrary St, Suite 200, San Luis Obispo, CA 93405 Phone: 805-781-0702    Fax: 888-255-4693

Karen A Kovalow-st. John, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 77 Casa St Ste 101, San Luis Obispo, CA 93405 Phone: 661-695-8385    Fax: 661-679-6801

Dr. Deneen Cherry Dicarlo, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 77 Casa St Ste 101, San Luis Obispo, CA 93405 Phone: 661-695-8385    Fax: 805-439-2765

Dr. John Charles Norris, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: California Mens Colony, Hwy 1, San Luis Obispo, CA 93409 Phone: 805-547-7911    Fax: 805-547-7583

Deepa Ragesh Panikkath, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 892 Aerovista Pl Ste 210, San Luis Obispo, CA 93401 Phone: 805-549-8023    Fax: 805-549-8252

News Archive

Pregnancy study finds strong association between two antidepressants and heart anomalies

Women who took the antidepressant fluoxetine during the first three months of pregnancy gave birth to four times as many babies with heart problems as women who did not and the levels were three times higher in women taking paroxetine.

UCLA study suggests lower BPS doses damage woman's egg cells

Bisphenol S, a chemical used to manufacture polycarbonate water bottles and many other products such as epoxy glues and cash receipts, is an increasingly common replacement for bisphenol A, the of which was discontinued because of concerns about its harmful effects on the reproductive system.

Vycor Medical's VBAS medical retraction device advances neurosurgical technology

Vycor Medical, Inc., a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.

Targeted intervention could help promote smoking cessation among dual users

E-cigarettes spark many concerns, especially when it comes to youth vaping. However, emerging evidence suggests that e-cigarettes can be a helpful tool in smoking cessation.

FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients

Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients (4 months to 16 years of age) at high risk of developing CMV disease.

Read more Medical News

› Verified 1 days ago